NSE: EXPLEOSOL | BSE: 533121

Strong Performer, Under Radar

Download real time

1098.20 -15.30 (-1.37%)

29.94% Fall from 52W High

8,024 NSE+BSE Volume

NSE 11 Aug, 2025 3:31 PM (IST)

1,704.4

Market Cap

Above industry Median

0.7

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Expleo Solutions Ltd. is on 14 Aug 2025 for the purpose of Quarterly Results See details

Expleo Solutions Ltd. share price target and research reports

Name: Latest research reports of Expleo Solutions Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: Expleo Solutions Ltd.
Rating: 5
Author: Karvy

Latest analyst research reports with target prices and PDF download for EXPLEOSOL, BSE:533121 Expleo Solutions Ltd.

Expleo Solutions Ltd.

15 Feb 2017

1098.20

-1.37%

SQS India BFSI Ltd: Weak Q3FY17 Due to Macro Environment Hea... (Feb 15, 2017)

Buy: Expleo Solutions Ltd.

Target

Karvy

Weak Q3FY17 Due to Macro Environment Headwinds:Drop in revenue; Margins slipped by 305 bps QoQ - In Q3FY17, SQS recorded revenue of Rs. 609 Mn compared to Rs. 684 Mn during Q2FY17 with a drop of11.0%. As business remains weak in UK and Middle East, uncertainty in the US market continues as regulations set to change are the primary resaons for revenuede-growth. Low utilization, hiring of senior level employees also impacted EBITDA margins which was dropped to 12.2% down by 305 bps QoQ and 355 bps YoY. SQSrecorded PAT of Rs. 38 Mn with a QoQ decline of 36.6%, due to the impact of weak operating performance and a forex loss of ~ Rs. 24mn in the quarter.

Expleo Solutions Ltd. is trading above its 150 day SMA of 1074.9

Expleo Solutions Ltd.

10 Feb 2017, 12:00AM

1098.20

-1.37%

Result Update:SQS India BFSI

Hold: Expleo Solutions Ltd.

Axis Direct

SQS India BFSI Ltd delivered a modest performance in Q3FY17, with the company's earnings (PAT) coming in at Rs 3.8 Cr, down 48.6% Y-o-Y on account of higher other expenses, decline in sales and forex loss. In Q3FY17, revenue of the company declined 9.2% Y-o-Y to Rs 60.9 Cr while other expenses inc..

Expleo Solutions Ltd. is trading above its 150 day SMA of 1074.9

Expleo Solutions Ltd.

01 Nov 2016

1098.20

-1.37%

SQS India BFSI Ltd: Flat Q2FY17; Expecting Sustainable Profitability Going Forwa... (Nov 01, 2016)

Buy: Expleo Solutions Ltd.

Target

Karvy

Drop in EBITDA Margin by 532 bps QoQ: In Q2FY17, operating revenue was Rs. 684 Mn compared to Rs. 731 Mn during Q1FY17 with a drop of 6.4%. This is due to Brexit voting which impacted in terms of Forex fluctuations and there is a planned decrease in the revenue from two large projects which were heading towards the end of the project milestones.

Expleo Solutions Ltd. is trading above its 150 day SMA of 1074.9

Expleo Solutions Ltd.

04 Jun 2016

1098.20

-1.37%

BP Equities SQS India BFSI Ltd Initiating Coverage

Buy: Expleo Solutions Ltd.

BP Wealth

Expleo Solutions Ltd. is trading below its 30 day SMA of 1227.3

Expleo Solutions Ltd.

23 Mar 2016

1098.20

-1.37%

SQS India BFSI Ltd: World's Leading Specialist in Financial Services Testing (Mar 23, 2016)

Buy: Expleo Solutions Ltd.

Karvy

Benefits from SQS Group drive growth opportunities: SQS India BFSI is now part of the SQS group, which is world's largest independent specialist testing company. Before acquisition, the consolidated revenue was Rs. 1,614 mn in FY13. Over FY13-FY15, the company recorded revenue growth at a CAGR of 15%. We estimate the revenue will grow at a CAGR of 14% in FY15-FY18E. Going ahead, margin expansion will continue from 17.3% in FY15 to 19.3% in FY18E due to revenue acceleration, changing business mix and employee cost rationalization.

Expleo Solutions Ltd. has gained 33.00% in the last 3 Months

Expleo Solutions Ltd.

31 Jul 2015

1098.20

-1.37%

SQS India BFSI Ltd.

Buy: Expleo Solutions Ltd.

Ashika Research

SQS India BFSI Ltd. (formerly known as Thinksoft Global Services Ltd) is an independent Business Assurance and Testing Specialist working entirely with financial sector clients in APAC, the USA,...

Expleo Solutions Ltd. is trading above its 150 day SMA of 1074.9

Is Expleo Solutions Ltd. worth buying?

103 Votes:

Buy 80.58%

Sell 10.68%

Hold 8.74%